
Biopharmaceuticals • Global Operations
As a leading biopharmaceutical company specialising in human protein products, Octapharma operates a complex global supply chain that serves patients worldwide with life-saving treatments. The company faced significant challenges in optimising their supply chain operations while maintaining the highest standards of quality and regulatory compliance.
With manufacturing facilities across multiple continents and stringent regulatory requirements, Octapharma needed to enhance operational efficiency, improve supply chain visibility, and strengthen their team's capabilities to manage increasingly complex global operations while ensuring patient safety remained paramount.
Grange partnered with Octapharma to design and implement a comprehensive supply chain optimisation and capability development programme. The solution focused on enhancing operational excellence across:
The programme delivered targeted training and process improvements that enhanced operational efficiency while maintaining the strict quality and safety standards required in biopharmaceutical manufacturing.
The partnership with Grange delivered significant improvements across Octapharma's global operations, enhancing both efficiency and compliance while maintaining the highest quality standards for their life-saving biopharmaceutical products.
Improved supply chain efficiency and reduced operational complexity across global manufacturing network.
Enhanced cross-functional collaboration and strengthened organisational capabilities for sustained performance.
"The collaboration with Grange has significantly enhanced our operational capabilities and helped us achieve new levels of excellence in our global supply chain operations. Their expertise in biopharmaceutical operations and commitment to quality alignment perfectly with our mission to improve patient outcomes."
Biopharmaceuticals
Global Operations